The project, the first under a partnership between the university and Illumina announced last year, will apply whole-genome sequencing to challenging cancers types.
An Australian team developed a decision model for testing asymptomatic relatives of patients with dilated cardiomyopathy to assess the cost effectiveness of testing.
